Announced

Completed

Novo Holdings completed the acquisition of BBI Group from Exponent for £400m.

Synopsis

Novo Holdings, a global life sciences investor, completed the acquisition of BBI Group, a supplier of products and services to the global diagnostics and life sciences industries, from Exponent, a private equity firm, for c.£400m ($564m). "We see tremendous opportunities for both organic and inorganic growth for the company. Novo Holdings is looking forward to contributing its considerable industry expertise and extensive network in supporting the talented team at BBI," Johan Hueffer, Novo Holdings Senior Partner.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US